BRYANA ANDERSON: Open Payments
NPI 1386001576 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 15 payments from 10 companies in 2025. Trend: 2023 $241 · 2024 $227 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $70 |
| Gilead Sciences, Inc. | 3 | $63 |
| PFIZER INC. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Aveo Pharmaceuticals, Inc. | 1 | $18 |
Products named: Trodelvy, Vyloy, OPDIVO, LIBTAYO, PADCEV, MONJUVI, INLYTA, Xtandi.
Industry payments across TX — which companies pay providers there.
